ISLET

A European funded project innovating advanced cell-therapy for Diabetes

[ISLET @ISLETeu]

Excited https://t.co/WDtR6p0CDH is part of @Unistemday2024 @HelmholtzMunich inspiring young people about #Science and how it effects our lives

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

Handcrafted Langerhans Islets - Hope for #Type1Diabetes?

💡Usually, beta cells help regulating our #blood sugar levels - but people with #T1D don't have those...
👉Learn more about #StemCell based beta cell replacement #therapy at #HelmholtzMunich:
🔗https://t.co/ZvyosiyrpU

[ISLET @ISLETeu]

Handcrafted Langerhans Islets: New Hope for Type 1 Diabetes Patients? - Helmholtz Munich https://t.co/BrV9oDmmbV

[ISLET @ISLETeu]

On #WorldDiabetesDay we celebrate all the #science research effort to improve the lives for those with #diabetes. @ISLETeu thanks its partners @IDFEuropeBXL for their insight whilst we bring #CellTherapy for diabetes to people. @eurostemcell @EuroGct

[Helmholtz Diabetes Center (HDC) @helmholtz_diabc]

🌍Today is #WorldDiabetesDay.

We are joining the worldwide movement to shine a light on #diabetes. 💙

Together, let's foster understanding, support groundbreaking research, and strive for a future where diabetes is better managed and prevented. 🧪🔬

[IDFEurope / Diabetes @IDFEuropeBXL]

🌍✨Happy #WorldDiabetesDay!

🥰Today we celebrate all #PwD and the importance of prioritising diabetes prevention and care & ensure existing commitments are met.

🚀 Our focus is not just celebration, but action!

🌐Together, United, Let’s Act on Diabetes🙌

#IfNotNowWhen

[IDFEurope / Diabetes @IDFEuropeBXL]

In the lead up to #WorldDiabetesDay, let’s raise awareness of the need to accelerate action towards the full adoption of integrated & novel care pathways to help PwD achieve the best possible quality of life.

🙌Together, United, Let’s Act on Diabetes🙌

➡️https://t.co/o5hnuvn5kU

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

#EDENT1FI: Early Detection of #Typ1Diabetes

💡Researchers, #industry & charities aim to combat #T1D in this international project.
👏The @IHIEuropenow supports with a grant!
👉Read about the team's vision & thoughts of co-leader Prof. Annette Ziegler: https://t.co/qpFSXo7nPQ

[ISLET @ISLETeu]

Developing future leaders in #CellTherapy #Diabetes @HydraSchool. @ISLETeu scientist Eunike bringing fresh expertise to her work. Thank you @HorizonEU for funding

[Eunike Setyono @EunikeSetyono]

It has been a wonderful week spent in Spetses, Greece for #SCSS2023 @HydraSchool. Learnt a bunch, met a wonderful group of people, and an overall fantastic time. Thank you for the organizers @_CellySally_, @kim_bak_jensen, Austin Smith for this awesome summer school!

[ISLET @ISLETeu]

Listening to #type1diabetes community helps scientists with research that is effective for those who need it 😀🙏@JDRFUK

[Breakthrough T1D UK @BT1DUK]

Time is of the essence! ⏰ If you're part of the #Type1Diabetes community, we want to know your thoughts on treatments and technologies.

Share your views in our short survey – it's quick, confidential, and impactful.

Take the survey now: https://t.co/n3bZ0vXgRX

#GBDoc #T1D

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

📝#PaperAlert: Early diagnosis of #Type1Diabetes improves subsequent treatment of the #autoimmune #disease.
💡If #T1D is diagnosed in a pre-symptomatic stage severe complications can be prevented.
👉More info about the new findings from the #Fr1da study: https://t.co/yTA5hDXnSE

[ISLET @ISLETeu]

We agree, collaboration is key! Thanks to @HorizonEU we are combining unique world leading expertise across disciplines to create a #celltherapy for #diabetes

[Horizon Europe 🇪🇺 @HorizonEU]

📌 The Horizon Europe Strategic Plan sets out the strategic orientation for #EU #research & #innovation

💡 You told us what challenges we should address more in the upcoming strategic plan!

Find out the results of the public consultation on the #FutureofRnI �📌 The Horizon Europe Strategic Plan sets out the strategic orientation for #EU #research & #innovation

💡 You told us what challenges we should address more in the upcoming strategic plan!

Find out the results of the public consultation on the #FutureofRnI �📌 The Horizon Europe Strategic Plan sets out the strategic orientation for #EU #research & #innovation

💡 You told us what challenges we should address more in the upcoming strategic plan!

Find out the results of the public consultation on the #FutureofRnI 👇

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

📝#PaperAlert: Treatment for #multimorbidity of #type2diabetes & #osteoarthritis?
💡A team around @ArrudaAnaLuiza & @EleZeggini @CompHealthMuc identified genes associated with both diseases that might offer a way for #Drug repurposing:
🔗https://t.co/ZC6mSFdS9a

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

❓Do you have exciting research findings in the field of #diabetes❓
👉Submit your #abstract and share it with the diabetes experts at the #HelmholtzDiabetes2023👇

@DiabResearch

[Breakthrough T1D UK @BT1DUK]

Volunteers needed for #research! 🙋

Researchers @DiabetesKings are seeking over 18s with #Type1Diabetes who use syringes or pens to inject insulin to help improve injection techniques by completing the 5-10min questionnaire below.

📝 https://t.co/32hmeZjC45

#GBDoc #T1D

[ISLET @ISLETeu]

ISLET is aiming to make cells ready for #clinicaltrials for treatment for #diabetes - what will happen next? Read about what a clinical trial is and why they are needed @EuroGct

[EuroGCT @EuroGct]

Join @EuroGCT in the #InternationalClinicalTrialDay celebrations. Read about #ClinicalTrials 👩‍🔬🔬👨‍🔬: how #ATMPs (#GeneTherapy and #CellTherapy) are being developed.
Available in: 🇬🇧🇪🇸🇩🇪🇵🇹🇮🇹🇫🇷🇵🇱

#ClinicalTrialDay #RareDisease

https://t.co/ai8mbyWYAA

[EuroGCT @EuroGct]

What sort of information would help you to make a decision about an advanced therapy? ATMP Engage want to hear from patients and patient advocates, carers, and other members of the public: https://t.co/zJSqWjAePE

[Heiko Lickert @LickertHeiko]

There are FDA approved trials coming up with these hypoimmunogenic cells - who knows which transplantation sites are used and what safety requirements need to be fulfilled?

[ISLET @ISLETeu]

The @labs_mann expertise in identifying and analysing cell markers means ISLET will spearhead efficient processes for detecting which beta cells and islet cells will be the most viable for transplant, currently a major roadblock in the cell-therapy pipeline to patients.

[Max Planck Institute of Biochemistry (MPIB) @MPI_Biochem]

Get to know the #MPIBDirectors!🤝
Today: Matthias Mann

Matthias, along with his team @labs_mann uses mass spectrometry-based proteomics to investigate the proteome, unraveling links between health and disease

#50yearsMPIB

❕more from the Mann Department
https://t.co/VK5rMsdxeS

[EuroGCT @EuroGct]

Are you involved in research into #GeneTherapy and #CellTherapy development?

Read our recently published article about principles of data processing, including #healthdata and #HumanGeneticData⬇️

#ATMPs
@EdinUni_IRR @crm_edinburgh @EdinUni_IGC
https://t.co/RoKm6EGzPE

[Helmholtz Munich | @HelmholtzMunich @HelmholtzMunich]

❓Did you know that type 1 diabetes can already occur in children❓
💡#Diabetes expert Prof Anette Ziegler explained at the SZ Health Forum why early detection of this autoimmune #disease is important.
👉Learn more about #type1diabetes at #HelmholtzMunich: https://t.co/bR9xfSetDe